Skip to main content
. 2025 Dec 11;26:96. doi: 10.1186/s12903-025-07497-8

Table 2.

DIAGNOdent values at each timepoint by treatment group showing Temporal changes from baseline (T0) to 6 months (T3)

Group Baseline (T0) Mean ± SD [95% CI] 1 Month (T1) Mean ± SD [95% CI] 3 Months (T2) Mean ± SD [95% CI] 6 Months (T3) Mean ± SD [95% CI] Δ (T3 − T0) Mean [95% CI] p-value †
Control (A) 10.4 ± 2.5 [8.7–12.2] 11.5 ± 2.5 [9.7–13.2] 12.2 ± 2.6 [10.3–14.1] 14.8 ± 2.6 [13.0–16.6] + 4.35 [3.77–4.93] < 0.001
CPP-ACP (B) 12.3 ± 1.5 [11.3–13.4] 11.1 ± 1.6 [10.0–12.3] 9.9 ± 1.3 [9.0–10.8] 8.3 ± 1.2 [7.4–9.2] −4.02 [− 4.47 to − 3.56] < 0.001
nHAp (C) 12.1 ± 0.7 [11.6–12.6] 10.0 ± 0.9 [9.3–10.6] 8.8 ± 0.7 [8.2–9.3] 6.7 ± 0.6 [6.2–7.1] −5.36 [− 5.99 to − 4.72] < 0.001
Fluoride (D) 12.1 ± 0.9 [11.5–12.7] 9.7 ± 1.1 [9.0–10.5] 10.8 ± 1.0 [10.1–11.6] 7.6 ± 0.8 [7.0–8.1] −4.45 [− 4.78 to − 4.11] < 0.001